Definitive Contract 75N95018C00035

Award Date 9/20/18
Potential Completion Date 11/29/19
Potential Value $477K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase 2 contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Soterix Medical, Inc. The $1,499,968.00 firm-fixed-price contract is for the development of a transcranial direct current stimulation (tDCS) system to reduce craving in individuals with cocaine addiction. The contract has a completion date of September 27, 2024 and is set aside for small businesses. Soterix...
This firm fixed-price purchase order contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Soterix Medical, Inc. (doing business as Soterix Medical Technologies), a manufacturer of medical devices and equipment. The $25,000.00 contract is for the delivery of Soterix Medical's non-invasive neuromodulation technologies, which have been used in past federal research and development efforts for treatments related to pain,...
This STTR Phase II contract for $749,983.00 was awarded by the Department of the Air Force Materiel Command Research Laboratory to Quantum Applied Science & Research Inc. (Quasar), a small business. The contract is for the development of a closed-loop feedback control system for transcranial direct current stimulation (tDCS). Major subcontractors include Soterix Medical Inc., a manufacturer of neuromodulation devices, and the Florida Institute for Human & Machine Cognition (IHMC), a...
This is a $806,041.38 cost-plus-fixed-fee task order awarded to The Emmes Company LLC by the National Institute on Drug Abuse (NIDA) for the "Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder (CTN-0108)" study. The task order, which has a period of performance from 9/21/2020 to 7/17/2023, is part of NIDA's "Data, Statistics, and Clinical Trial Support Center" major program. The Emmes Company, a for-profit limited liability company...
The Department of Health and Human Services' National Institute on Drug Abuse awarded a $10,455 firm-fixed-price purchase order contract to Brainbox LTD, a for-profit company specializing in non-invasive brain stimulation and imaging solutions. The purpose of the contract is to provide Brainbox's K-Plan software to be used with a transducer to modulate neural activity in deeper areas of the human brain, in support of research conducted by Drs. Ross and Kahnt. The contract has an ultimate...
This is a $224,833 firm-fixed-price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Soterix Medical, Inc., doing business as Soterix Medical Technologies, a small business manufacturer of medical devices and equipment. The contract is for the research and development of a "Galvanic Vestibular Stimulation as a Novel, Hands-Free, and Intuitive Interface Modality" under DARPA's Small Business Innovation Research (SBIR) Program Phase I. Soterix Medical has...
This federal contract award, valued at $86,060.00, was made by the National Institute on Drug Abuse (NIDA) to Magventure, Inc., a medical device manufacturer that specializes in transcranial magnetic stimulation (TMS) systems. The award is for the procurement of an MRI-compatible TMS Neuronavigation System, which will be used to support biomedical research projects at NIDA. This was a non-competitive, brand-name contract, with no set-aside designation. Based on Magventure's past contract history...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Program Phase I contract to B & W TEK Inc., a for-profit manufacturing organization, to develop new commercially viable devices, tools, technologies or integrated systems for drug detection and deactivation to deter opioid theft in hospitals. The definitive, firm fixed-price contract has a potential value of $224,656.02 and a...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $24,250.00, is for the delivery of Brainbox LTD's NEUROFUS DEEP TRANSDUCER, a specialized medical device used to modulate neural activity in deeper areas of the human brain. This technology supports NIDA's research efforts, which include the study of addiction and other neurological conditions. The...
S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small...

This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Soterix Medical, Inc. for a Small Business Innovation Research (SBIR) Phase I project to develop transcranial direct current stimulation (tDCS) technology to reduce craving in cocaine addiction. The base award has a potential value of $476,863.98 and a period of performance from September 2018 to November 2019. Soterix Medical is a manufacturer of medical devices and equipment, with a history of federal contract awards to support research and development of non-invasive neuromodulation technologies for treatment of various conditions. This award falls under a broader SBIR solicitation from HHS/NIH and CDC focused on innovative research to meet program objectives, with set-aside contracts for eligible small businesses.

Generated 3/24/24, 8:43 AM